Karbon-X Corp. (KARX) Stock Forecast Oct. 16, 2026
Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · OTC
Karbon-X Corp. (KARX) stock forecast summary
Our AI ranks Karbon-X Corp. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Karbon-X Corp. is a small-cap company with a market capitalization of $18M. It ranks number 15 by market capitalization among the 19 Perfumes, Cosmetics & Other Toilet Preparations issuers in our coverage with a current forecast. Its Gross Margin of 1.4% is the lowest of the 15 peers that report one.
For KARX, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -29.0%, measured on 274 forecast dates between 2024-03-01 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -26.0%, measured on 317 forecast dates between 2024-03-01 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, KARX included.
Follow KARX freeKARX price chart and AI forecast
How KARX ranks among 5172 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Karbon-X Corp. (KARX) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Perfumes, Cosmetics & Other Toilet Preparations peers listed below that report each metric.
Valuation & Market
| Metric | KARX | Rank |
|---|---|---|
| Market Cap | $18M | 15/19 |
| EPS | $-0.07 | – |
Profitability & Margins
| Metric | KARX | Rank |
|---|---|---|
| Gross Margin | 1.4% | 15/15 |
| Operating Margin | -14.3% | 14/16 |
| EBT Margin | -16.8% | 14/16 |
| Tax Rate | 0.0% | – |
Financial Health
| Metric | KARX | Rank |
|---|---|---|
| Interest Coverage | 4.1x | 6/13 |
Cash Flow
| Metric | KARX | Rank |
|---|---|---|
| Operating Cash Flow | -$6M | 16/18 |
Income Statement
| Metric | KARX | Rank |
|---|---|---|
| Operating Income | -$9M | 14/17 |
| Cost of Goods Sold | $60M | 9/16 |
Dividend & Shareholder Information
| Metric | KARX | Rank |
|---|---|---|
| Shares Outstanding | 99M | – |
Balance Sheet Highlights (USD millions)
| Total Liabilities | $27M |
KARX quarterly financials and insider trading
Karbon-X Corp. (KARX) industry peers
Companies classified under the same SEC industry code as Karbon-X Corp. (Perfumes, Cosmetics & Other Toilet Preparations): 19 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| KARX Karbon-X Corp. | ▼ | $18M |
| CL Colgate Palmolive Co | ▼ | $75.02B |
| HLN Haleon Plc | ▼ | $44.72B |
| EL Estee Lauder Companies Inc | ▼ | $37.82B |
| KVUE Kenvue Inc. | ▼ | $36.32B |
| ELF E.L.F. Beauty, Inc. | ▶ | $6.70B |
| IPAR Interparfums Inc | ▶ | $3.71B |
| COTY Coty Inc. | ▲ | $2.82B |
| EPC Edgewell Personal Care Co | ▼ | $1.29B |
| ODD Oddity Tech Ltd | ▲ | $1.03B |
| WALD Waldencast Plc | ▲ | $100M |
| SLSN Solesence, Inc. | ▲ | $64M |
| SHFH Scientist Home Future Health Ltd | ▼ | $40M |
| AXIL Axil Brands, Inc. | ▲ | $37M |
| UG United Guardian Inc | ▲ | $31M |
| DQWS Dswiss Inc | ▶ | $17M |
| CABR Caring Brands, Inc. | ▲ | $13M |
| BNKK Bonk, Inc. | ▼ | $10M |
| YCBD Cbdmd, Inc. | ▲ | $4M |
Where KARX sits on the market map
Karbon-X Corp. (KARX) stock news
Loading...
Karbon-X Corp. (KARX) stock forecast FAQ
What is the Karbon-X Corp. (KARX) stock forecast?
Our AI ranks Karbon-X Corp. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Karbon-X Corp. stock predictions?
For KARX, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -29.0%, measured on 274 forecast dates between 2024-03-01 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -26.0%, measured on 317 forecast dates between 2024-03-01 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Karbon-X Corp. forecasts updated?
Karbon-X Corp. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
Which companies are Karbon-X Corp.'s industry peers?
19 issuers in our coverage, KARX included, share the SEC industry code Perfumes, Cosmetics & Other Toilet Preparations. The largest are: Colgate Palmolive Co (CL), Haleon Plc (HLN), Estee Lauder Companies Inc (EL), Kenvue Inc. (KVUE), E.L.F. Beauty, Inc. (ELF), Interparfums Inc (IPAR).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.